Top News

May 21, 2015
The House Energy and Commerce Committee gave unanimous approval to the landmark 21st Century Cures Act reform bill on May 21, 2015.
May 20, 2015
By Pharmaceutical Technology Editors
The former New England Compounding Center will pay $200 million to victims and creditors for the 2012 outbreak of meningitis that killed 64.
May 20, 2015
By Pharmaceutical Technology Editors
The new guideline replaces the previous version—CHMP/EWP/240/95 Revision 1.
May 18, 2015
By Pharmaceutical Technology Editors
The Irish company Endo International announced that it would acquire Par Pharmaceutical for $8.05 billion.
May 07, 2015
The US Court of Appeals granted Amgen’s request to block Novartis’ Neupogen biosimilar, Zarxio, from the US market until the court resolves litigation between the two companies.
May 07, 2015
By Pharmaceutical Technology Editors
BASF announces that it will sell its custom synthesis business and parts of its API business to focus its expertise on pharmaceutical excipients.
May 06, 2015
By Pharmaceutical Technology Editors
Eleven of the leading US biosimilar developers have collaborated to form the Biosimilars Forum, a nonprofit organization formed to expand patient access to biosimilars.
May 06, 2015
By Pharmaceutical Technology Editors
Alexion announces it will expand its rare disease pipeline with a definitive agreement to acquire Synageva.
Apr 30, 2015
By Pharmaceutical Technology Editors
Takeda Pharmaceutical agrees to pay $2.4 billion to settle lawsuits from patients and family members who said the diabetes drug Actos caused bladder cancer.
Apr 30, 2015
By Pharmaceutical Technology Editors
Perrigo rejected Mylan’s second proposal for an acquisition valued at more than $34 billion, saying that the offer was too low to consider.
native1_300x100
lorem ipsum